Pharmacokinetics and safety of rifabutin in young HIV-infected children receiving rifabutin and lopinavir/ritonavir

OBJECTIVES: Co-treatment of HIV and TB in young children is complicated by limited treatment options and complex drug–drug interactions. Rifabutin is an alternative to rifampicin for adults receiving a ritonavir-boosted PI. We aimed to evaluate the short-term safety and pharmacokinetics of rifabutin...

Descripción completa

Detalles Bibliográficos
Autores principales: Moultrie, Harry, McIlleron, Helen, Sawry, Shobna, Kellermann, Tracy, Wiesner, Lubbe, Kindra, Gurpreet, Gous, Hermien, Van Rie, Annelies
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4291235/
https://www.ncbi.nlm.nih.gov/pubmed/25281400
http://dx.doi.org/10.1093/jac/dku382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4291235/
https://www.ncbi.nlm.nih.gov/pubmed/25281400
http://dx.doi.org/10.1093/jac/dku382

Ejemplares similares